Andelyn Biosciences uses AAV curator platform to deliver novel gene therapy for ultra-rare NEDAMSS… EP News Bureau May 13, 2025 The platform allows for the ability to support the exacting viral vector manufacturing needs of different types of patients
Andelyn Biosciences selected to manufacture AAV therapies under CIRM EP News Bureau May 27, 2024 The partnership aims to advance BGTC’s mission to develop platforms and standards to propel the development and delivery of…
